Drug Profile
Ovarian cancer DNA vaccine
Latest Information Update: 23 Apr 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Cancer vaccines; DNA vaccines; Gene therapies
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Ovarian cancer
Most Recent Events
- 12 Aug 1999 New profile
- 12 Aug 1999 Preclinical development for Ovarian cancer in Italy (Unknown route)